The bone marrow disease myelofibrosis is stimulated by excessive signaling from vitamin D and immune cells known as macrophages, reveals a research team. These findings could help to develop alternative treatments that do not target problem genes.
The bone marrow disease myelofibrosis is stimulated by excessive signaling from vitamin D and immune cells known as macrophages, reveals a research team. These findings could help to develop alternative treatments that do not target problem genes.